Following its review of cough and cold medication use in children, the Irish Medicines Board (IMB) no longer advises their use in children under six years of age.
The decision comes soon after a similar conclusion was reached by the FDA in America. In it's letter to healthcare professionals the IMB states that: "These recommendations reflect an evolution in the therapeutic strategy over time for the management of coughs and colds in children rather than the emergence of any new safety concern."